|
| |
| | 67281 | | 28.05.2020 | | Bayer (Schweiz) AG | | | | | | 19.02.2029 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Vitrakvi 25 mg | Kapseln | Capsules (Larotrectinibum 25 mg) | L01EX12 | CI | 02 | Vitrakvi 100 mg | Kapseln | Capsules (Larotrectinibum 100 mg) | L01EX12 | |
|
|
|